NO2482815T3 - - Google Patents
Info
- Publication number
- NO2482815T3 NO2482815T3 NO10759934A NO10759934A NO2482815T3 NO 2482815 T3 NO2482815 T3 NO 2482815T3 NO 10759934 A NO10759934 A NO 10759934A NO 10759934 A NO10759934 A NO 10759934A NO 2482815 T3 NO2482815 T3 NO 2482815T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24833809P | 2009-10-02 | 2009-10-02 | |
| PCT/EP2010/064687 WO2011039365A1 (en) | 2009-10-02 | 2010-10-01 | Anti inflammatory 2-oxothiazoles and 2 -oxooxazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2482815T3 true NO2482815T3 (es) | 2018-09-29 |
Family
ID=43221889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO10759934A NO2482815T3 (es) | 2009-10-02 | 2010-10-01 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9597318B2 (es) |
| EP (2) | EP2482815B1 (es) |
| JP (1) | JP6012468B2 (es) |
| KR (4) | KR20190082985A (es) |
| CN (3) | CN102647984B (es) |
| AU (1) | AU2010302584B2 (es) |
| CA (1) | CA2782797C (es) |
| DK (1) | DK2482815T3 (es) |
| HK (2) | HK1197551A1 (es) |
| IN (1) | IN2012DN02982A (es) |
| NO (1) | NO2482815T3 (es) |
| WO (1) | WO2011039365A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2482815T3 (es) | 2009-10-02 | 2018-09-29 | ||
| GB201205394D0 (en) | 2012-03-27 | 2012-05-09 | Adlens Ltd | Improvements in or relating to deformable non-round membrane assemblies |
| GB201221329D0 (en) | 2012-11-27 | 2013-01-09 | Avexxin As | Dermatitis treatment |
| CN110128370A (zh) * | 2013-01-29 | 2019-08-16 | 埃维克辛公司 | 抗炎症和抗肿瘤的2-氧代噻唑类和2-氧代噻吩类化合物 |
| GB201307331D0 (en) * | 2013-04-23 | 2013-05-29 | Norwegian Univ Sci & Tech Ntnu | Compound |
| GB201409363D0 (en) | 2014-05-27 | 2014-07-09 | Avexxin As | Skin cancer treatment |
| GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
| GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| GB2550363A (en) * | 2016-05-16 | 2017-11-22 | Avexxin As | Compound |
| AU2017329957B2 (en) | 2016-09-21 | 2020-05-07 | Avexxin As | Pharmaceutical composition |
| CN109922833A (zh) * | 2016-11-04 | 2019-06-21 | 埃维克辛公司 | 治疗皮肤病症的包含噻唑和皮质类固醇的联合治疗 |
| AU2017353450B2 (en) * | 2016-11-04 | 2020-09-10 | Avexxin As | Combination therapy comprising a thiazole and a secosteroid to treat skin conditions |
| JP7169584B2 (ja) * | 2018-01-30 | 2022-11-11 | 公立大学法人横浜市立大学 | オーキシン生合成阻害活性を有する新規化合物、その製造方法及びその用途 |
| GB201806663D0 (en) | 2018-04-24 | 2018-06-06 | Avexxin As | 2-Oxothiazole compositions for treatment of fibrotic disease |
| EP3677259A1 (en) * | 2019-01-07 | 2020-07-08 | Mosaiques Diagnostics And Therapeutics AG | Use of arachidonyl trifluoromethyl ketone |
| GB202117609D0 (en) | 2021-12-06 | 2022-01-19 | Coegin Pharma Ab | 2-Oxothiazole compositions for treatment of T-cell acute lymphoblastic leukaemia |
| CN115028597B (zh) * | 2022-04-29 | 2024-03-26 | 闽都创新实验室 | 一种tempo连续脱氢环化制备苯并恶唑类衍生物的方法和应用 |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3894152A (en) * | 1969-09-15 | 1975-07-08 | Innothera Lab Sa | Use of (thienyl-3)(3-N-morpholine-propy)ketone |
| FR2062868B1 (es) * | 1969-09-15 | 1973-08-10 | Innothera Lab Sa | |
| DE2063901A1 (en) | 1970-12-28 | 1972-07-20 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Phenylalkylaminoalkylthiazoles - as antiphlogistics |
| PH22520A (en) | 1984-11-12 | 1988-10-17 | Yamanouchi Pharma Co Ltd | Heterocyclic compounds having 4-lover alkyl-3-hydroxy-2-lower alkyl phenoxy-lower alkylene-y-group, and process of producing them |
| US5177215A (en) | 1984-11-12 | 1993-01-05 | Yamanouchi Pharmaceutical Co., Ltd. | Heterocyclic compounds and pharmaceutical use thereof |
| JPS62142168A (ja) | 1985-10-16 | 1987-06-25 | Mitsubishi Chem Ind Ltd | チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤 |
| ZA894913B (en) | 1988-07-12 | 1990-03-28 | Ici Pharma | Heterocyclic compounds |
| US5272986A (en) | 1991-05-13 | 1993-12-28 | British Gas Plc | Towing swivel for pipe inspection or other vehicle |
| TW263504B (es) | 1991-10-03 | 1995-11-21 | Pfizer | |
| GB9211706D0 (en) | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
| US5273986A (en) | 1992-07-02 | 1993-12-28 | Hoffmann-La Roche Inc. | Cycloalkylthiazoles |
| US5268395A (en) | 1992-10-13 | 1993-12-07 | Martin Marietta Energy Systems, Inc. | Microcellular carbon foam and method |
| JP3345476B2 (ja) * | 1993-05-18 | 2002-11-18 | 株式会社東芝 | 有機非線形光学材料 |
| US5569655A (en) * | 1993-09-14 | 1996-10-29 | Sterling Winthrop Inc. | Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof |
| WO1996003392A1 (en) | 1994-07-27 | 1996-02-08 | G.D. Searle & Co. | Substituted thiazoles for the treatment of inflammation |
| US6214994B1 (en) * | 1997-04-21 | 2001-04-10 | Molecular Geriatrics Corporation | Certain substituted 1-aryl-3-piperazin-1′-yl propanones |
| US5693804A (en) * | 1994-11-17 | 1997-12-02 | Molecular Geriatrics Corporation | Substituted 1-aryl-3-piperazin-1'-yl propanones |
| US5658909A (en) * | 1994-11-17 | 1997-08-19 | Molecular Geriatrics Corporation | Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease |
| TW438786B (en) | 1995-03-28 | 2001-06-07 | Nippon Zoki Pharmaceutical Co | Novel benzothiazole derivatives |
| WO1996036617A1 (en) * | 1995-05-19 | 1996-11-21 | G.D. Searle & Co. | Substituted oxazoles for the treatment of inflammation |
| CA2224121A1 (en) * | 1995-06-06 | 1996-12-12 | Donna Kaye Wilson | Stereoselective method for synthesizing dolaphenine |
| DE19638408A1 (de) * | 1996-09-19 | 1998-03-26 | Merckle Gmbh | 1-Substituierte 3-Acyl-4,5-dimethylpyrrol-2-carbonsäuren und 3-Acylindol-2-carbonsäuren sowie ihre Derivate als Hemmstoffe der cytosolischen Phospholipase A¶2¶ |
| JP2001509156A (ja) * | 1997-01-29 | 2001-07-10 | ゼネカ・リミテッド | ファルネシルプロテイントランスフェラーゼの阻害剤 |
| EP0867437B1 (en) | 1997-03-14 | 2002-11-13 | Koninklijke Philips Electronics N.V. | "Method of preparing a thiophene-containing or furan -containing conjugated compound and precursor compound used therein". |
| WO1999015129A2 (en) * | 1997-09-23 | 1999-04-01 | Bristol-Myers Squibb Company | SELECTIVE cPLA2 INHIBITORS |
| JPH11255700A (ja) | 1998-03-12 | 1999-09-21 | Taiho Ind Co Ltd | アセチルアセトン系金属錯体及びその合成法、並びにそれを用いた有機多層型エレクトロルミネッセンス素子 |
| KR20010071975A (ko) | 1998-08-11 | 2001-07-31 | 해슬러 요세 | 살선충성 피라졸 |
| SE9804212D0 (sv) * | 1998-12-04 | 1998-12-04 | Astra Pharma Prod | Compounds |
| EP1196384A4 (en) | 1999-06-25 | 2002-10-23 | Merck & Co Inc | 1- (AROMATIC OR HETEROAROMATICALLY SUBSTITUTED) -3- (HETEROAROMATICALLY SUBSTITUTED) -1,3-PROPANDIONS AND THEIR APPLICATIONS |
| JP2001240593A (ja) * | 1999-10-12 | 2001-09-04 | Japan Tobacco Inc | 高トリグリセリド血症治療薬及び抗肥満薬 |
| US6462054B1 (en) * | 2000-03-27 | 2002-10-08 | The Scripps Research Institute | Inhibitors of fatty acid amide hydrolase |
| CN1429224A (zh) | 2000-05-18 | 2003-07-09 | 第一制药株式会社 | 新颖苯并噻吩衍生物 |
| US20020052373A1 (en) * | 2000-10-26 | 2002-05-02 | Zorn Stevin H. | Combination treatment for dementia or cognitive deficits associated with alzheimer's disease and parkinson's disease |
| US6734207B2 (en) * | 2001-04-20 | 2004-05-11 | Parker Hughes Institute | Cytotoxic compounds |
| US7056917B2 (en) | 2001-04-26 | 2006-06-06 | Daiichi Pharmaceutical Co., Ltd. | Drug efflux pump inhibitor |
| WO2003051194A1 (en) | 2001-12-18 | 2003-06-26 | 3Cpm Company | Endoscopic measurement of myoelectrical activity from intra-abdominal organs |
| GB0202002D0 (en) * | 2002-01-29 | 2002-03-13 | Leiv Eiriksson Nyotek A S | Use |
| CA2494668A1 (en) | 2002-07-27 | 2004-02-05 | Astrazeneca Ab | Chemical compounds |
| SE0202463D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Novel compounds |
| US6930391B2 (en) | 2002-08-27 | 2005-08-16 | Intel Corporation | Method for alloy-electroplating group IB metals with refractory metals for interconnections |
| BR0314980A (pt) * | 2002-10-08 | 2005-08-09 | Scripps Research Inst | Inibidores de hidrolase de amida de ácido graxo |
| GB2394894B (en) | 2002-11-04 | 2005-08-31 | G W Pharma Ltd | New use for pharmaceutical composition |
| AU2003276458A1 (en) | 2002-11-07 | 2004-06-07 | Astrazeneca Ab | 2-oxo-ethanesulfonamide derivates |
| JP4663523B2 (ja) | 2003-09-18 | 2011-04-06 | 株式会社トクヤマ | クロメン化合物 |
| SA04250288B1 (ar) * | 2003-09-19 | 2008-07-19 | سولفاي فارماسوتيكالز بي . في | مشتقات ثيازول thiazole كمعدلات لمستقبل المكونات الكيميائية للقنب cannabinoid |
| JP4226438B2 (ja) | 2003-10-23 | 2009-02-18 | エヌ・ティ・ティ・コムウェア株式会社 | パック装置およびセンステーブル装置、ならびに移動軌跡算出方法、移動軌跡算出プログラム、その記録媒体 |
| US20050137243A1 (en) | 2003-12-23 | 2005-06-23 | Souers Andrew J. | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| JP2005343889A (ja) * | 2004-05-06 | 2005-12-15 | Taisho Pharmaceut Co Ltd | イミダゾピリジン誘導体 |
| CN102816130B (zh) * | 2004-05-17 | 2015-05-06 | 大塚制药株式会社 | 噻唑化合物及其用途 |
| US7178364B2 (en) | 2004-07-22 | 2007-02-20 | Shapiro Kristen M | Personal adornment |
| WO2006016218A1 (en) * | 2004-08-03 | 2006-02-16 | Pfizer Japan Inc. | Aryl or heteroaryl carbonyl derivatives derivatives useful as vanilloid receptor 1 (vr1) antagonists |
| WO2006057503A1 (en) * | 2004-11-25 | 2006-06-01 | Lg Life Sciences, Ltd. | NOVEL COMPOUNDS AS AGONIST FOR PPARϜ AND PPARα, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME |
| WO2007061862A2 (en) * | 2005-11-18 | 2007-05-31 | Janssen Pharmaceutica N.V. | 2-keto-oxazoles as modulators of fatty acid amide hydrolase |
| UA116187C2 (uk) * | 2005-12-13 | 2018-02-26 | Інсайт Холдінгс Корпорейшн | ГЕТЕРОАРИЛЗАМІЩЕНІ ПІРОЛО[2,3-b]ПІРИДИНИ Й ПІРОЛО[2,3-b]ПІРИМІДИНИ ЯК ІНГІБІТОРИ ЯНУС-КІНАЗИ |
| CA2642737A1 (en) | 2006-02-17 | 2007-08-30 | The Scripps Research Institute | Oxazole ketones as modulators of fatty acid amide hydrolase |
| WO2008013963A2 (en) * | 2006-07-28 | 2008-01-31 | University Of Connecticut | Fatty acid amide hydrolase inhibitors |
| CA2678735A1 (en) | 2007-02-26 | 2008-09-04 | Santen Pharmaceutical Co., Ltd. | Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| MX2009009121A (es) * | 2007-03-05 | 2009-09-03 | Hoffmann La Roche | Aminoamidas como antagonistas de orexina. |
| CA2689148A1 (en) * | 2007-05-31 | 2008-12-11 | The Scripps Research Institute | Tricyclic inhibitors of fatty acid amide hydrolase |
| NO2482815T3 (es) | 2009-10-02 | 2018-09-29 | ||
| CN103228641A (zh) | 2010-11-22 | 2013-07-31 | 日立化成株式会社 | 稀土类金属络合物 |
| CN110128370A (zh) * | 2013-01-29 | 2019-08-16 | 埃维克辛公司 | 抗炎症和抗肿瘤的2-氧代噻唑类和2-氧代噻吩类化合物 |
| GB201413695D0 (en) * | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
-
2010
- 2010-10-01 NO NO10759934A patent/NO2482815T3/no unknown
- 2010-10-01 CN CN201080056033.8A patent/CN102647984B/zh active Active
- 2010-10-01 CN CN201310675185.1A patent/CN103772312B/zh active Active
- 2010-10-01 DK DK10759934.2T patent/DK2482815T3/en active
- 2010-10-01 KR KR1020197018997A patent/KR20190082985A/ko not_active Application Discontinuation
- 2010-10-01 KR KR1020127011173A patent/KR20120089701A/ko active Application Filing
- 2010-10-01 AU AU2010302584A patent/AU2010302584B2/en active Active
- 2010-10-01 KR KR1020187028820A patent/KR101997163B1/ko active IP Right Grant
- 2010-10-01 EP EP10759934.2A patent/EP2482815B1/en active Active
- 2010-10-01 EP EP18170271.3A patent/EP3431084A1/en not_active Withdrawn
- 2010-10-01 JP JP2012531448A patent/JP6012468B2/ja active Active
- 2010-10-01 CN CN201510086534.5A patent/CN104892542B/zh active Active
- 2010-10-01 CA CA2782797A patent/CA2782797C/en active Active
- 2010-10-01 IN IN2982DEN2012 patent/IN2012DN02982A/en unknown
- 2010-10-01 WO PCT/EP2010/064687 patent/WO2011039365A1/en active Application Filing
- 2010-10-01 KR KR1020177008521A patent/KR101907535B1/ko active IP Right Grant
- 2010-10-04 US US12/897,510 patent/US9597318B2/en active Active
-
2014
- 2014-11-05 HK HK14111229.4A patent/HK1197551A1/zh not_active IP Right Cessation
-
2015
- 2015-11-05 HK HK15110908.3A patent/HK1210157A1/xx unknown
-
2017
- 2017-02-24 US US15/442,568 patent/US10370344B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2482815B1 (en) | 2018-05-02 |
| AU2010302584A1 (en) | 2012-05-24 |
| CA2782797A1 (en) | 2011-04-07 |
| US10370344B2 (en) | 2019-08-06 |
| KR20120089701A (ko) | 2012-08-13 |
| EP3431084A1 (en) | 2019-01-23 |
| IN2012DN02982A (es) | 2015-07-31 |
| CN103772312A (zh) | 2014-05-07 |
| KR20190082985A (ko) | 2019-07-10 |
| CN102647984B (zh) | 2015-03-25 |
| JP6012468B2 (ja) | 2016-10-25 |
| CN104892542B (zh) | 2018-01-26 |
| CA2782797C (en) | 2018-08-07 |
| CN102647984A (zh) | 2012-08-22 |
| KR101997163B1 (ko) | 2019-07-08 |
| KR20180114228A (ko) | 2018-10-17 |
| KR101907535B1 (ko) | 2018-10-15 |
| AU2010302584B2 (en) | 2015-09-10 |
| HK1210157A1 (en) | 2016-04-15 |
| US20170166539A1 (en) | 2017-06-15 |
| KR20170038941A (ko) | 2017-04-07 |
| CN103772312B (zh) | 2016-08-17 |
| EP2482815A1 (en) | 2012-08-08 |
| DK2482815T3 (en) | 2018-06-06 |
| WO2011039365A1 (en) | 2011-04-07 |
| US20110136879A1 (en) | 2011-06-09 |
| JP2013506639A (ja) | 2013-02-28 |
| CN104892542A (zh) | 2015-09-09 |
| US9597318B2 (en) | 2017-03-21 |
| HK1197551A1 (zh) | 2015-01-23 |